The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A case-control study of community-associated Clostridium difficile infection
Open accessAbstract
OBJECTIVES: The aim of this study was to determine the incidence of and risk factors for community-associated Clostridium difficile infection (CDI). METHODS: Prospective surveillance of community-derived faecal samples for C. difficile cytotoxin, followed by a questionnaire-based case-control study in two distinct patient cohorts (one semi-rural and the other urban). RESULTS: The proportion of randomly selected faecal samples positive for C. difficile cytotoxin was 2.1% in both patient cohorts (median ages 73 and 45 years for the urban and semi-rural cohorts, respectively). Exposure to antibiotics in the previous 4 weeks, particularly multiple agents (P < 0.001), aminopenicillins (P < 0.05) and oral cephalosporins (P < 0.05), was significantly more frequent among cases than controls. Hospitalization in the preceding 6 months was significantly associated with CDI (45% versus 23%; P = 0.022). However, almost half the cases had not received antibiotic therapy in the month before C. difficile detection, and approximately one-third neither had exposure to antibiotics nor recent hospitalization. Contact with infants aged < or =2 years was significantly associated with CDI (14% versus 2%; P = 0.02). Prior exposure to gastrointestinal-acting drugs (proton pump inhibitor, H2 antagonist or non-steroidal anti-inflammatory) was not significantly more common in CDI cases. C. difficile PCR ribotype 001 caused 60% and 13% of urban and semi-rural community-associated CDI cases, respectively. CONCLUSIONS: Reliance on antibiotic history and age (> or =65 years) will contribute to missed diagnoses of community-associated CDI. Potential risk factors for community-associated CDI should be explored further to explain the large proportion of cases not linked to recent antibiotic therapy or hospitalization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 904
Wheeler, J. G., Sethi, D., Cowden, J. M., Wall, P. G., Rodrigues, L. C., Tompkins, D. S., Hudson, M. J., & Roderick, P. J. (1999) · BMJ · doi:10.1136/bmj.318.7190.1046 · Cited by 794 · cited 14×
“There is an unresolved controversy concerning proton pump inhibitors as a potential risk factor in CDI.”
BackgroundMethodInfluentialFinancial burden of hospital-acquired Clostridium difficile infection
Wilcox, M. H., Cunniffe, J. G., Trundle, C., & Redpath, C. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90122-x · Cited by 244
Self-citationEpidemiology of Community-Acquired Clostridium difficile-Associated Diarrhea
Hirschhorn, L. R., Trnka, Y., Onderdonk, A., Lee, M.-L. T., & Platt, R. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.127 · Cited by 237
Dial, S. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060284 · Cited by 218
Clostridium difficile in Long-Term–Care Facilities for the Elderly
Simor, A. E., Bradley, S. F., Strausbaugh, L. J., Crossley, K., Nicolle, L. E., & SHEA Long-Term–Care Committee (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/501997 · Cited by 218
A Prospective Nationwide Study of Clostridium difficile‐Associated Diarrhea in Sweden
Karlström, O. H., Fryklund, B. A., Tullus, K., BURMAN, L. G., & the Swedish C. difficile Study Group (1998) · Clinical Infectious Diseases · doi:10.1086/516277 · Cited by 177
Cited by
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Self-citationBurden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380
Clostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
Self-citationThe Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 826
Self-citationThe epidemiology of community-acquired Clostridium difficile infection: a population-based study
Khanna, S., Pardi, D. S., Aronson, S. L., Kammer, P. P., Orenstein, R., St Sauver, J. L., Harmsen, S. W., & Zinsmeister, A. R. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.398 · Cited by 622
Crobach, M. J. T., Planche, T., Eckert, C., Barbut, F., Terveer, E. M., Dekkers, O. M., Wilcox, M. H., & Kuijper, E. J. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.03.010 · Cited by 596
Self-citationMeta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection
Brown, K. A., Khanafer, N., Daneman, N., & Fisman, D. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02176-12 · Cited by 587
Bavishi, C., & DuPont, H. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04874.x · Cited by 480
Current Status of Clostridium difficile Infection Epidemiology
Lessa, F. C., Gould, C. V., & McDonald, L. C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis319 · Cited by 439
Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection
Howell, M. D. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.89 · Cited by 437
Crobach, M. J. T., Dekkers, O. M., Wilcox, M. H., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03098.x · Cited by 413
Self-citationEpidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011
Chitnis, A. S., Holzbauer, S. M., Belflower, R. M., Winston, L. G., Bamberg, W. M., Lyons, C., Farley, M. M., Dumyati, G. K., Wilson, L. E., Beldavs, Z. G., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.7056 · Cited by 405
Community-associated Clostridium difficile infection and antibiotics: a meta-analysis
Deshpande, A., Pasupuleti, V., Thota, P., Pant, C., Rolston, D. D. K., Sferra, T. J., Hernandez, A. V., & Donskey, C. J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt129 · Cited by 404
Ferreyra, J. A., Wu, K. J., Hryckowian, A. J., Bouley, D. M., Weimer, B. C., & Sonnenburg, J. L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.003 · Cited by 378
Clostridium difficile infection: epidemiology, risk factors and management
Ananthakrishnan, A. N. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.190 · Cited by 352
Eastwood, K., Else, P., Charlett, A., & Wilcox, M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01082-09 · Cited by 330
Self-citationClostridium difficile infection: epidemiology, diagnosis and understanding transmission
Martin, J. S. H., Monaghan, T. M., & Wilcox, M. H. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.25 · Cited by 319
Self-citationGlobal burden of Clostridium difficile infections: a systematic review and meta-analysis
Balsells, E., Shi, T., Leese, C., Lyell, I., Burrows, J., Wiuff, C., Campbell, H., Kyaw, M. H., & Nair, H. (2019) · Journal of Global Health · doi:10.7189/jogh.09.010407 · Cited by 309
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
Sheen, E., & Triadafilopoulos, G. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1560-3 · Cited by 307
Clostridium difficile infection in the community: a zoonotic disease?
Hensgens, M. P. M., Keessen, E. C., Squire, M. M., Riley, T. V., Koene, M. G. J., de Boer, E., Lipman, L. J. A., & Kuijper, E. J. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03853.x · Cited by 290
Wiegand, P. N., Nathwani, D., Wilcox, M. H., Stephens, J., Shelbaya, A., & Haider, S. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.02.004 · Cited by 280
Self-citationProton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
Linsky, A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.73 · Cited by 276
Metadata
- Authors
- Wilcox, M. H., Mooney, L., Bendall, R., Settle, C. D., & Fawley, W. N.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-31
- Volume
- 62
- Issue
- 2
- Pages
- 388-396
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2128490444
- Cited by
- 372
- References
- 29
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.